CervoMed
CRVO
20 hedge funds and large institutions have $2.94M invested in CervoMed in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.12% → 0.13% (+0%)
17% less funds holding
Funds holding: 24 → 20 (-4)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
39% less capital invested
Capital invested by funds: $4.8M → $2.94M (-$1.86M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
+$93.4K |
| 2 |
VF
Virtu Financial
New York
|
+$63.1K |
| 3 |
Renaissance Technologies
New York
|
+$40.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$21.1K |
| 5 |
Jane Street
New York
|
+$9.48K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$60K |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$51K |
| 3 |
WSTAM
Wilbanks Smith & Thomas Asset Management
Norfolk,
Virginia
|
-$22K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.1K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$8K |
CRVO Hedge Fund Activity: Q4 2021 in Review
20 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q4 2021, worth a combined $2.94M — down 39% from $4.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CRVO and 4 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 5 added.
The largest buyer was Two Sigma Advisers, opening a new position worth an estimated $93.4K. The largest seller was Citadel Advisors, exiting entirely with an estimated $60K sold.
- 20 institutional investors held CervoMed (CRVO) as of Q4 2021, down from 24 in Q3 2021.
- Funds reported $2.94M of CervoMed stock for Q4 2021, down 39% quarter-over-quarter.
- 4 funds opened new CervoMed positions in Q4 2021 and 6 closed out, a net change of -2 holders.
- The largest CervoMed buyer in Q4 2021 was Two Sigma Advisers, an estimated $93.4K added.
- The largest CervoMed seller in Q4 2021 was Citadel Advisors, an estimated $60K sold.
Based on aggregated 13F filings for Q4 2021.